{"id":10152,"date":"2024-08-18T06:02:43","date_gmt":"2024-08-18T06:02:43","guid":{"rendered":"https:\/\/cobrca.org\/?page_id=10152"},"modified":"2024-08-28T13:29:40","modified_gmt":"2024-08-28T13:29:40","slug":"novartis-symposium","status":"publish","type":"page","link":"https:\/\/cobrca.org\/cobrca2024\/novartis-symposium\/","title":{"rendered":"Novartis Symposium"},"content":{"rendered":"<h3><strong>Breakfast Industry Symposium:<br \/>\nSharing clinical experience with eligible women with HR+\/HER2- advanced breast cancer \u2013 interactive case studies and panel discussions<br \/>\n<\/strong><span style=\"font-size: 8pt;\"><strong><em>This promotional symposium has been organised and funded by Novartis Pharmaceuticals UK Ltd.<br \/>\nNovartis products will be discussed at this symposium and prescribing information will be available from a Novartis representative during the symposium<\/em><\/strong><\/span><\/h3>\n<h3><span style=\"color: #ed4d9b;\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-10062\" src=\"https:\/\/cobrca.org\/cobrca2024\/wp-content\/uploads\/2024\/08\/novartis_logo_pos_rgb-300x55.jpg\" alt=\"\" width=\"300\" height=\"55\" srcset=\"https:\/\/cobrca.org\/cobrca2024\/wp-content\/uploads\/2024\/08\/novartis_logo_pos_rgb-300x55.jpg 300w, https:\/\/cobrca.org\/cobrca2024\/wp-content\/uploads\/2024\/08\/novartis_logo_pos_rgb-1024x187.jpg 1024w, https:\/\/cobrca.org\/cobrca2024\/wp-content\/uploads\/2024\/08\/novartis_logo_pos_rgb-768x140.jpg 768w, https:\/\/cobrca.org\/cobrca2024\/wp-content\/uploads\/2024\/08\/novartis_logo_pos_rgb-1536x280.jpg 1536w, https:\/\/cobrca.org\/cobrca2024\/wp-content\/uploads\/2024\/08\/novartis_logo_pos_rgb-260x47.jpg 260w, https:\/\/cobrca.org\/cobrca2024\/wp-content\/uploads\/2024\/08\/novartis_logo_pos_rgb-50x9.jpg 50w, https:\/\/cobrca.org\/cobrca2024\/wp-content\/uploads\/2024\/08\/novartis_logo_pos_rgb-150x27.jpg 150w, https:\/\/cobrca.org\/cobrca2024\/wp-content\/uploads\/2024\/08\/novartis_logo_pos_rgb.jpg 1780w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/strong><\/span><\/h3>\n<p><span style=\"color: #ed4d9b;\"><strong>Thursd<\/strong><\/span><span style=\"color: #ed4d9b;\"><strong>ay, September 12, 2024<br \/>\n07:30-08:30<br \/>\nHALL B<br \/>\n<\/strong><\/span><em>Light refreshments will be served prior to the session from 7:00<\/em><\/p>\n<table style=\"width: 100%; height: 95px;\">\n<tbody>\n<tr style=\"height: 25px;\">\n<td style=\"width: 105px; text-align: left; vertical-align: top; height: 25px;\"><strong>Chairperson:<\/strong><\/td>\n<td style=\"text-align: left; height: 25px;\"><strong>Marina Parton<\/strong>, <em>\u00a0London, UK<\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 100px; text-align: left; vertical-align: top;\">07:30-07:50<\/td>\n<td style=\"text-align: left;\">Case Study &#8211; an older adult with advanced breast cancer<br \/>\n<strong>Alistair Ring,<\/strong> <em>London, UK<\/em><\/td>\n<\/tr>\n<tr style=\"height: 10px;\">\n<td style=\"width: 100px; text-align: left; vertical-align: top; height: 10px;\">07:50-08:10<\/td>\n<td style=\"text-align: left; height: 10px;\">Case Study &#8211; an advanced breast cancer patient with cardiac co-morbidities<br \/>\n<strong>Olga Oikonomidou<\/strong>,<em>\u00a0 Edinburgh, Scotland, UK<\/em><\/td>\n<\/tr>\n<tr style=\"height: 50px;\">\n<td style=\"width: 100px; text-align: left; vertical-align: top; height: 50px;\">08:10-08:30<\/td>\n<td style=\"text-align: left; height: 50px;\">Case Study &#8211; an advanced breast cancer patient with visceral metastasis<br \/>\n<strong>Mark Verrill<\/strong>,<em> Newcastle upon Tyne, UK<\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"text-align: right;\"><em>UK I August 2024 I FA-11253802<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Breakfast Industry Symposium: Sharing clinical experience with eligible women with HR+\/HER2- advanced breast cancer \u2013 interactive case studies and panel discussions This promotional symposium has been<span class=\"excerpt-hellip\"> [\u2026]<\/span><\/p>\n","protected":false},"author":12,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-10152","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/pages\/10152"}],"collection":[{"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/comments?post=10152"}],"version-history":[{"count":9,"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/pages\/10152\/revisions"}],"predecessor-version":[{"id":10215,"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/pages\/10152\/revisions\/10215"}],"wp:attachment":[{"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/media?parent=10152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}